Bristol Myers Squibb warns US price reforms will dent drug development

20 November 2022 - Biggest shake-up in pharma pricing in decades prompts companies to shelve some potential therapies. ...

Read more →

Big pharma may have to reveal government deals in WHO's draft pandemic rules

17 November 2022 - Pharmaceutical companies could be made to disclose prices and deals agreed for any products they make ...

Read more →

US Government is talking to companies about drug price negotiations

21 October 2022 - The US Government is holding talks with health insurers and drug makers as it sets up ...

Read more →

New Zealand, it's time to put Fairness in Focus

20 October 2022 - Medicines New Zealand is today relaunching their digital public awareness platform Fairness in Focus.  ...

Read more →

Europe's generic drugmakers say they may cut output due to energy bills

28 September 2022 - Europe's drugmakers have warned they may stop making some cheap generic medicines because of surging electricity ...

Read more →

The Inflation Reduction Act aims to lower drug costs — but here’s how big pharma could get around it

21 September 2022 - The tactics may ultimately threaten the law’s ability to lower drug costs for many in the US. ...

Read more →

FDA’s drug industry fees fuel concerns over influence

15 September 2022 - The pharmaceutical industry finances about 75% of the agency’s drug division, through a controversial program that ...

Read more →

FDA boldly bows to big pharma at Americans’ expense

29 August 2022 - A Wall Street Journal headline went this way: “Latest Covid Boosters Are Set to Roll Out ...

Read more →

AstraZeneca's Soriot warns new US drug price law will hurt innovation

23 August 2022 - AstraZeneca's Chief Executive Pascal Soriot warned on Tuesday new US legislation capping drug prices would reduce ...

Read more →

Drug pricing reforms can hurt innovation. Here are 3 ways to prevent that.

22 August 2022 - Giving billions of dollars in government prize money to drug companies might sound like an idea from ...

Read more →

US move to negotiate drug prices a rare defeat for big pharma

12 August 2022 - Big pharma spent more than any other industry to lobby Congress and federal agencies this year, ...

Read more →

PhRMA’s Ubl calls Senate passage of partisan drug pricing plan a “tragic loss for patients”

7 August 2022 - PhRMA President and CEO Stephen J. Ubl released the following statement after the U.S. Senate passed ...

Read more →

Critics decry drug pricing provisions in Inflation Reduction Act, say they will stifle innovation

2 August 2022 - The push back against the prescription drug pricing provisions in the Inflation Reduction Act is relentless and ...

Read more →

FDA official: patients play an increasing role in rare disease drug development

1 August 2022 - Patients have a critical role in drug development, from identifying unmet medical needs to assessing meaningful ...

Read more →

Despite their anger over high drug prices, Americans are giving pharma credit for helping contain COVID-19

26 July 2022 - Nearly three quarters of Americans give the pharmaceutical industry credit for helping contain COVID-19 — and for ...

Read more →